Altria Pulls NJOY ACE As Smoke Free Investment Focus Shifts

Simply Wall St

Thu, February 19, 2026 at 3:13 PM GMT+9 2 min read

In this article:

MO

+0.35%

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

Altria Group (NYSE:MO) has removed its NJOY ACE e vapor product from retail shelves due to regulatory issues.

The company does not expect to reintroduce NJOY ACE in 2026.

Altria is increasing investment in its broader smoke free portfolio during this period.

For you as an investor, this move sits at the intersection of regulation and product mix. Altria, long known for its Marlboro cigarettes in the US, has been building a smoke free portfolio that includes e vapor and oral nicotine products. The decision around NJOY ACE adds a new dimension to how that transition takes shape.

The key question now is how Altria reallocates capital and commercial focus within its smoke free range while NJOY ACE is off the shelf. As more regulatory scrutiny shapes which products can stay in the market, the mix and timing of Altria’s offerings could play an important role in how its reduced risk segment evolves.

Stay updated on the most important news stories for Altria Group by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Altria Group.

NYSE:MO 1-Year Stock Price Chart

Is Altria Group’s balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis.

Quick Assessment

**❌ Price vs Analyst Target**: At US$66.77, the share price sits about 5.6% above the US$63.25 analyst consensus target.

**✅ Simply Wall St Valuation**: Shares are described as trading about 41.7% below estimated fair value.

**✅ Recent Momentum**: The 30 day return of roughly 8.1% shows short term positive price action.

There is only one way to know the right time to buy, sell or hold Altria Group. Head to Simply Wall St’s company report for the latest analysis of Altria Group’s Fair Value.

Key Considerations

📊 NJOY ACE stepping back from shelves concentrates the smoke free story on other products. You will want to judge whether that lineup can carry the reduced risk thesis.

📊 Keep an eye on smoke free revenue contribution, R&D and capex allocations, and any regulatory progress that might open or close product options.

⚠️ Existing flags around dividend coverage and a high level of debt mean that funding this investment shift without stretching the balance sheet further is a key watchpoint.

Dig Deeper

For the full picture, including more risks and rewards, check out the complete Altria Group analysis. Alternatively, you can visit the community page for Altria Group to see how other investors believe this latest news will impact the company’s narrative.

Story Continues  

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include MO.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info